Clinical Trials · NCT04311424
Study of Tirzepatide in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 6
- Start date
- Jul 2020
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Urinary Excretion of Tirzepatide Radioactivity Over Time Expressed As A Percentage of the Total Radioactive Dose Administered